Advertisement
Australia markets close in 3 hours 41 minutes
  • ALL ORDS

    8,005.10
    -5.40 (-0.07%)
     
  • ASX 200

    7,762.80
    -6.90 (-0.09%)
     
  • AUD/USD

    0.6670
    -0.0003 (-0.04%)
     
  • OIL

    81.38
    -0.19 (-0.23%)
     
  • GOLD

    2,349.80
    +2.90 (+0.12%)
     
  • Bitcoin AUD

    97,622.45
    -317.09 (-0.32%)
     
  • CMC Crypto 200

    1,383.45
    +45.69 (+3.42%)
     
  • AUD/EUR

    0.6208
    +0.0002 (+0.04%)
     
  • AUD/NZD

    1.0881
    +0.0008 (+0.07%)
     
  • NZX 50

    11,728.63
    +57.44 (+0.49%)
     
  • NASDAQ

    19,908.86
    +6.11 (+0.03%)
     
  • FTSE

    8,205.11
    +13.82 (+0.17%)
     
  • Dow Jones

    38,834.86
    +56.76 (+0.15%)
     
  • DAX

    18,067.91
    -64.06 (-0.35%)
     
  • Hang Seng

    18,421.59
    -8.80 (-0.05%)
     
  • NIKKEI 225

    38,302.50
    -268.26 (-0.70%)
     

If You Invested $10,000 in Invitae in 2018, This Is How Much You Would Have Today

If You Invested $10,000 in Invitae in 2018, This Is How Much You Would Have Today

Genetic testing company Invitae (NYSE: NVTA) has a lot of long-term potential as it could help improve the quality of healthcare for people and play a big role in transforming the industry. Below, I'll look at how much a $10,000 investment in the company would be worth today, and whether you should consider buying shares today. In 2018, Invitae was coming off a year where its revenue totaled $68 million and had more than doubled the prior-year's tally of $25 million.